Management of multiple myeloma during COVID-19 pandemic

Y. S. Jethava, Rafael Fonseca, Ola Landgren

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

At the end of 2019, a novel coronavirus was identified as the cause of pneumonia cases in Wuhan, a city in the Hubei Province of China. On January 30, 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a public health emergency of international concern and, in March 2020, began to characterize it as a pandemic. The virus that causes COVID-19 is designated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) In February 2020, the World Health Organization designated the disease COVID-19, which stands for coronavirus disease 2019.

Original languageEnglish (US)
Article number100212
JournalLeukemia Research Reports
Volume14
DOIs
StatePublished - 2020

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Management of multiple myeloma during COVID-19 pandemic'. Together they form a unique fingerprint.

Cite this